A phase 2 study of frontline pembrolizumab in follicular lymphoma.
Ho C, Zhu S, Gooley T, Gujral TS, Lynch RC, Poh C, Shadman M, Smith SD, Tseng Y, Gopal AK.
Ho C, et al. Among authors: lynch rc.
EJHaem. 2024 Oct 10;5(6):1173-1181. doi: 10.1002/jha2.1029. eCollection 2024 Dec.
EJHaem. 2024.
PMID: 39691260
Free PMC article.